Bottom line
GMNCX vs TRGLX: the short answer
GMNCX (Gabelli Global Mini Mites Fund) and TRGLX (T. Rowe Price Global Stock Fund) are both mutual funds.
Updated Nov 19, 2026
GMNCX vs TRGLX side by side
| GMNCX | TRGLX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Innovator | T. Rowe Price |
| Category | Global Stock | Global Stock |
| Expense ratio | — | 0.66% |
| Annual cost per $10k | — | $66 |
| 10-yr cost on $10k (prospectus) | — | $822 |
| Max front load | — | — |
| 12b-1 fee | — | 0% |
| 1-yr return | — | +17.0% |
| 5-yr return (annualized) | — | +12.3% |
| 10-yr return (annualized) | — | — |
| Best quarter | — | +31.1% |
| Worst quarter | — | −20.4% |
| Net assets (fund) | $27.0M | $8.3B |
| Number of holdings | 173 | 138 |
| Portfolio turnover | 29% | 172% |
| Returns as of | — | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
GMNCX and TRGLX share none of their top holdings.
GMNCX top 10
- Park-ohio Holdings Corp — 5.03%
- United States Of America - Bureau Of The Public Debt — 4.31%
- Ampco Pittsburgh Corp — 4.12%
- Tredegar Corp — 3.95%
- United States Of America - Bureau Of The Public Debt — 3.66%
- United States Of America - Bureau Of The Public Debt — 3.53%
- Entravision Communications Corp — 3.38%
- United States Of America - Bureau Of The Public Debt — 3.04%
- Myers Industries Inc — 2.75%
- United States Of America - Bureau Of The Public Debt — 2.01%
TRGLX top 10
- Nvidia Corp — 5.60%
- Taiwan Semiconductor Manufac — 3.53%
- Apple Inc — 3.23%
- Alphabet Inc Cl A — 2.90%
- Microsoft Corp — 2.50%
- Unitedhealth Group Inc — 2.39%
- Amazon.com Inc — 2.33%
- Asml Holding Nv — 2.24%
- Unilever Plc — 2.20%
- Broadcom Inc — 2.19%
FAQ
What is the difference between GMNCX and TRGLX?
GMNCX (Gabelli Global Mini Mites Fund) and TRGLX (T. Rowe Price Global Stock Fund) are both mutual funds.
Should I own both GMNCX and TRGLX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.